India, Jan. 6 -- Materials and energy stocks are among the top gainers in the Canadian market where the mood remains somewhat cautious on Tuesday with investors digesting the data on the nation's manu... Read More
India, Jan. 6 -- The Centers for Disease Control and Prevention has reduced the number of recommended vaccinations for children from 17 to 11. The new US childhood immunization schedule that CDC annou... Read More
India, Jan. 6 -- Venezuelan opposition leader Maria Corina Machado has praised U.S. President Donald Trump over the U.S. military's capture of President Nicolas Maduro. In an interview to Fox News, M... Read More
India, Jan. 6 -- The United States has justified at UN Security Council its military strikes on the Venezuelan capital and seizure of President Nicolas Maduro. The Security Council met on Monday agai... Read More
India, Jan. 6 -- Johnson & Johnson (JNJ) on Tuesday reported positive topline results from the Phase 2b JASMINE study of nipocalimab in adults with systemic lupus erythematosus (SLE). The study met i... Read More
India, Jan. 6 -- Genprex, Inc. (GNPX) on Tuesday reported preliminary preclinical data showing its diabetes gene therapy candidate GPX-002 improved glucose control in Type 2 diabetes animal models. I... Read More
India, Jan. 5 -- President Donald Trump has warned new Venezuelan leader Delcy Rodriguez ahead of her swearing in that she could "pay a very big price, probably bigger than Maduro" if she "doesn't do ... Read More
India, Jan. 5 -- Polyrizon Ltd. (PLRZ), Monday announced positive results from a new in-vitro pre-clinical study, evaluating the allergen-blocking performance of its PL-14 Allergy Blocker formulation ... Read More
India, Jan. 5 -- Genelux Corporation (GNLX) on Monday reported interim results from two ongoing trials evaluating Olvi-Vec in patients with progressive lung cancer: a Phase 1b/2 study in small cell lu... Read More
India, Jan. 5 -- Zenas BioPharma (ZBIO) reported positive results from the Phase 3 INDIGO trial of obexelimab in Immunoglobulin G4-Related Disease. Obexelimab met the primary endpoint, demonstrating 5... Read More